Emergent BioSolutions

EBSNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$249.726 M

$4.84 -8.85%

Close of 7 Aug 2026

Revenue

$742.9M

#1703 by revenue

Earnings

$52.6M

#1551 by earnings

Shares outstanding

51,273,336

Latest filing cover page

P/E ratio

4.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#252Whitehawk TherapeuticsWHWK$256.0M
#253Akebia TherapeuticsAKBA$252.1M
#254Emergent BioSolutionsEBS$249.7M
#255Sol-Gel TechnologiesSLGL$247.3M
#256AC ImmuneACIU$240.2M

Where these numbers come from

Share counts and financials for Emergent BioSolutions are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.